University Of Foggia
- Address
- Via Antonio Gramsci 89/91, 71122 Foggia, Italy
University Of Foggia - Neurodegenerative Disease Research
The University of Foggia is actively engaged in advanced clinical research focused on neurodegenerative disorders, with particular emphasis on innovative therapeutic approaches for Alzheimer's disease. The center participates in international multi-center trials investigating novel combination therapies aimed at improving cognitive outcomes in patients with dementia.
- Combination pharmacological therapies for mild to moderate Alzheimer's disease
- Frontal lobe cognitive function assessment and intervention strategies
- Dopaminergic and cholinergic system modulation in neurodegenerative conditions
The research team specializes in evaluating the efficacy of rotigotine in combination with rivastigmine, exploring how dual-mechanism approaches targeting both dopaminergic and cholinergic pathways may enhance cognitive function. Through rigorous phase 3 clinical trials utilizing validated assessment tools such as the Frontal Assessment Battery (FAB), the center contributes to the advancement of treatment options for patients experiencing cognitive decline associated with Alzheimer's disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Fondazione Santa Lucia1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in University Of Foggia
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Rotigotine and Rivastigmine Combination Therapy on Cognitive Function in Mild to Moderate Alzheimer's Disease: A Phase III Randomized Controlled Trial | Fondazione Santa Lucia | Phase III | Recruiting | Oct 2023 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Rotigotine | 1 | Unknown | 2023-10-25 | 2023-10-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.